Tonix Pharmaceuticals Holding Corp. (TNXP) › Capital ExpendituresTonix Pharmaceuticals Holding Corp. (TNXP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $34.3K2011: $2.8K2012: $36.0K2013: $15.0K2014: $319.0K2015: $118.0K2016: $66.0K2017: $5.0K2018: $6.0K2019: $17.0K2020: $8.56M2021: $35.31M2022: $48.15M2023: $7.89M2024: $120.0K2025: $3.37M$3.37M2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$3.37M+2707.5%2024$120.0K-98.5%2023$7.89M-83.6%2022$48.15M+36.4%2021$35.31M+312.3%2020$8.56M+50276.5%2019$17.0K+183.3%2018$6.0K+20.0%2017$5.0K-92.4%2016$66.0K-44.1%2015$118.0K-63.0%2014$319.0K+2026.7%2013$15.0K-58.3%2012$36.0K+1202.5%2011$2.8K-91.9%2010$34.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share